Prophylactic ophthalmic bethametazone for sulfur mustard-induced ocular injury

Mostafa Naderi1, Gholam-Reza Kaka, Khosro Jadidi

  • 1Department of Ophthalmology, School of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Abstract

Insights

Bethametazone demonstrated a protective effect against sulfur mustard (SM) ocular damage in rabbits. This corticosteroid reduced key morphometric changes in the cornea, conjunctiva, and eyelids following SM exposure.

Area of Science:

  • Ophthalmology
  • Toxicology
  • Pharmacology

Background:

  • Sulfur mustard (SM) causes significant ocular morphometric damage.
  • Evaluating prophylactic treatments for SM-induced eye injuries is crucial.

Purpose of the Study:

  • To assess the prophylactic efficacy of bethametazone against sulfur mustard-induced ocular morphometric damage in a rabbit model.

Main Methods:

  • Twenty-five rabbits were divided into four groups: control, solution-exposed, SM-exposed, and prophylactic bethametazone-treated.
  • Ocular tissues were analyzed using light microscopy on day 14 post-exposure.
  • Morphometric parameters were compared to evaluate bethametazone's protective effects.

Main Results:

  • Bethametazone significantly reduced SM-induced changes in corneal thickness, corneal epithelium thickness, and keratoctye count.
  • It also decreased alterations in meibomian gland cell count, palpebral conjunctival epithelium thickness, and palpebral skin epithelial thickness.
  • The number of epithelial layers in palpebral skin and goblet cells in the conjunctival sac were also improved by bethametazone.

Conclusions:

  • Bethametazone exhibits potential prophylactic effects against early-stage ocular lesions induced by sulfur mustard.
  • This finding suggests bethametazone as a possible therapeutic agent for SM-related eye injuries.